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Abstract: In the United States, new regulations on second-generation anticoagulant rodenticides will likely be offset by expanded use of
first-generation anticoagulant rodenticides. In the present study, eastern screech-owls (Megascops asio) were fed 10mg diphacinone/g
wet weight food for 7 d, and recovery was monitored over a 21-d postexposure period. By day 3 of exposure, diphacinone (DPN) was
detected in liver (1.63mg/g wet wt) and kidney (5.83mg/g) and coagulopathy was apparent. By day 7, prothrombin time (PT) and
Russell’s viper venom time (RVVT) were prolonged, and some individuals were anemic. Upon termination of exposure, coagulopathy
and anemia were resolved within 4 d, and residues decreased to <0.3mg/g by day 7. Liver and kidney DPN elimination occurred in
2 phases (initial rapid loss, followed by slower loss rate), with overall half-lives of 11.7 d and 2.1 d, respectively. Prolonged PT and
RVVT occurred in 10% of the exposed owls with liver DPN concentrations of 0.122mg/g and 0.282mg/g and in 90% of the owls with
liver concentrations of 0.638mg/g and 0.361mg/g. These liver residue levels associated with coagulopathy fall in the range of values
reported in raptor mortality incidents involving DPN. These tissue-based toxicity reference values for coagulopathy in adult screech-
owls have application for interpreting nontarget mortality and assessing the hazard of DPN in rodent-control operations. Diphacinone
exposure evokes toxicity in raptors within a matter of days; but once exposure is terminated, recovery of hemostasis occurs rapidly.
Environ Toxicol Chem 2014;33:74–81.# 2013 SETAC. This article is a US Government work and is in the public domain in the USA.
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INTRODUCTION
Anticoagulant rodenticides are used for the control of
vertebrate pest species in urban and suburban settings,
agriculture, and island restoration projects. Despite widespread
use, there are growing concerns about their risk to children,
companion and domestic animals, and nontarget wildlife. In the
United States, new restrictions have been placed on the use of
some second-generation anticoagulant rodenticide baits in and
around buildings [1,2]. This regulatory action will probably
result in expanded use of some first-generation anticoagulant
rodenticides that are considered to be less hazardous than
second-generation anticoagulant rodenticides [3].
Although first-generation anticoagulant rodenticides (e.g.,
chlorophacinone, diphacinone, warfarin) are considered to be
less hazardous, they have nonetheless been implicated in
nontarget wildlife mortality incidents. For example, diphacinone
(DPN) has been identified as a potential cause of unintentional
wildlife mortality involving owls (barn owl [Tyto alba], snowy
owl [Nyctea scandiaca]), hawks (Cooper’s hawk [Accipiter
cooperii], red-tailed hawk [Buteo jamaicensis]), and scavenging
birds (turkey vulture [Cathartes aura], bald eagle [Haliaeetus
leucocephalus]) [4–7]. Recent studies have demonstrated that
DPN is approximately 20 to 30 times more acutely toxic to
American kestrels (Falco sparverius) than reported for
traditionally used wildlife test species (mallard [Anas platyr-
hynchos] and northern bobwhite [Colinus virginianus]) [8].
Sublethal exposure of kestrels and eastern screech-owls
(Megascops asio) resulted in prolonged clotting time, reduced
hematocrit, and/or gross and histological evidence of hemor-
rhage at daily doses as low as 0.24mg DPN/kg body weight
(cumulative dose 1.68mg/kg) [8,9]. Incorporating these kestrel
and owl data into a deterministic risk assessment conducted by
the US Environmental Protection Agency [6] and into a
probabilistic risk assessment indicated that adverse effects
associated with DPN exposure occur at very low levels and that
its hazard has been underestimated by risk assessments that
rely on acute toxicity test scenarios and on data generated in
bobwhites and mallards [10,11].
The present study in eastern screech-owls examined clotting
time and tissue residues during dietary exposure to DPN and the
time course of recovery from coagulopathy and residue
clearance following termination of exposure. Using these
data, estimates of liver DPN residues associated with adverse
effects were undertaken tomore fully evaluate the hazard of first-
generation anticoagulant rodenticides to raptorial birds.
MATERIALS AND METHODS
Animals
All procedures involving animals were reviewed and
approved by the Institutional Animal Care and Use Committees
of the Patuxent Wildlife Research Center and the National
Wildlife Research Center. Eastern screech-owls, propagated in
flight pens in a captive colony at Patuxent [12], were sexed by
gene amplification (CHD1-Z and CHD1-W) using real-time
polymerase chain reaction analysis [13]. A total of 40 owls
(n¼ 24 males and 16 females) were used in the present study.
Birds were moved from flight pens to small, shaded outdoor
cages (1.2m long 0.8m wide 0.6m high) containing 2
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perches, a food tray, and a water bowl. Owls were offered dead
laboratory mice (Mus musculus; Charles River Laboratories, fed
5L79 rodent chow containing 3.4 ppm dry wt vitamin K) for 2
wk, at which time a jugular venipuncture sample (0.9mL in a 1-
mL syringe containing 0.1mL of 3.2% sodium citrate; Sigma-
Aldrich) was collected from each bird to determine baseline
clotting time. Microhematocrit (50mL) was determined on each
sample. The remainder of the blood sample was centrifuged
(2000 g for 5min), citrated plasma was harvested, divided into 3
vials that were stored at 80 8C, and subsequently used to
establish baseline clotting times. Owls were then fed Classic
Bird of Prey diet (containing 2.63 ppm dry wt vitamin K;
Nebraska Brand) supplemented with Vionate (Gimborn US) for
2 wk. Individuals that readily consumed the Bird of Prey diet
during this acclimation period (n¼ 37; 33 fed DPN, 4 controls),
along with 3 owls (additional controls) that would only consume
mice, were included in the DPN study. The dosing trial was
conducted between 24 October and 21 November 2011 (ambient
temperature 1.1 8C to 20.6 8C), and initial body weight
(mean standard deviation [SD]) of owls was 171.8 21.71 g.
Diphacinone toxicity and recovery study
Neat DPN was dissolved in acetone, and then corn oil was
added (1:20) to yield nominal concentrations of 1.0mg/mL. The
acetone–corn oil vehicle (control) and the DPN solution were
mixed into the Bird of Prey diet at a ratio of 1:100, followed by
the evaporation of acetone [9]. The control and DPN diets
containing nominal concentrations of 0mg and 10mg DPN/g
wet weight (analytically verified, see Diphacinone purity and
concentrations in diet and tissues) were formed into meatballs
weighing 25.0 0.1 g on a wet weight basis and stored at
20 8C. The 10mg/g wet weight dietary concentration falls
within the range of residues detected in the liver of small
mammals (less than the method limit of detection to 12mg/g)
collected following aerial broadcast application of DPN (Ramik
Green, 0.005% DPN; Hacco) for rodent control in Mauna Loa,
Hawaii, USA (E.B. Spurr, Pacific Island Ecosystem Research
Center, USGeological Survey, Honolulu, HI, unpublished data).
Owls were provided two 25-g meatballs daily for up to 7 d
and then shifted to an untreated diet (dead mice) for up to 21 d.
Birds were observed 3 times daily (7:00–8:00 AM, 12:00–1:00
PM, 4:00–5:00 PM) during the trial. Just before daily feeding
(4:00–5:00 PM), uneaten meatball scraps were collected from
the kraft paper–lined pens and saved to estimate DPN
consumption (i.e., difference between quantity fed and not
eaten, including conversion of dry wt mass back to wet wt) [9].
Groups of DPN-treated owls were weighed, bled, killed, and
necropsied on day 3 and day 7 of the exposure period (n¼ 5/d,
sexes divided nearly equal) and on day 1, day 2, day 4, day 7, and
day 21 during the postexposure period (n¼ 5 owls/d except on
day 21, when n¼ 3; sexes nearly equal). Controls (n¼ 4)
received a similar but untreated diet containing the acetone–corn
oil vehicle, and additional controls (n¼ 3) were fed mice
throughout the trial. A single control owl was weighed and bled
each time DPN-treated birds were killed during the course of the
exposure and postexposure periods; however, only 4 of 7
controls were killed and necropsied. Microhematocrit values
were determined, and plasma samples for clotting time assays
and liver and kidney samples for quantification of DPN residues
were stored at 80 8C.
Clotting time assays
Prothrombin time (PT) and Russell’s viper venom time
(RVVT) of plasma samples were used to evaluate DPN effects
on posttranslational processing of clotting factors II, VII, IX, and
X; and thrombin clotting time (TCT) was used to insure sample
quality (i.e., adequate fibrinogen concentration to promote
clotting). The assay of PT, RVVT, and TCT in eastern screech-
owl samples has been described in detail [9]. The coefficients of
variation for duplicate determinations of all PT and RVVT
samples (mean SD) were 8.8 8.38% and 4.2 5.15%,
respectively. As previously noted [9], precision deteriorated in
samples with clotting time >100 s (extreme coagulopathy). For
the TCT assay, the fibrinogen concentration of all DPN-exposed
owls exceeded 50mg/dL, with the precision of duplicate
determinations being 2.4 2.87%.
Diphacinone purity and concentrations in diet and tissues
The purity of neat DPN was determined by reversed-phase,
ion-paired high-performance liquid chromatography (HPLC)
with ultraviolet detection at 285 nm and found to be 99.2%
(%w/w) [8]. The Bird of Prey diet and liver and kidney samples
were homogenized, solvent extracted, prepped using solid-phase
extraction cartridges, and DPNwas quantified by reversed-phase
ion-paired HPLC [9]. The recovery of DPN from spiked control
samples (mean SD) was 99.1 10.29% for liver (n¼ 11) and
100.6 7.80% for kidney (n¼ 8). Recovery of the DPN
(nominal concentration 10mg/g wet wt) from fortified meatballs
(n¼ 3 meatballs from each of 4 batches) was 98.3 9.08%, and
no DPN was detected in the control meatballs (n¼ 3). For liver
and kidney samples, the method limit of detection and method
limit of quantification were 0.049mg/g and 0.16mg/g wet weight
for liver and 0.12mg/g and 0.41mg/g wet weight for kidney,
respecitvely.
Statistical analyses
Body weight change, hematocrit, PT, RVVT, TCT, and DPN
consumption and residues were tested for homogeneity of
variances (Fmax test) and normality (Shapiro-Wilk test, normal
probability plot), and transformed when appropriate. Diphaci-
none concentrations below the detection limit were assigned a
value of one-half the method limit of detection. Measurement
end points were compared by one-way analysis of variance and
Tukey’s honestly significant difference test. The relations
between DPN residues (liver, kidney) and clotting time (PT,
RVVT) were examined using linear regression.
Liver and kidney residue half-life estimates were conducted
by using DPN concentrations at the end of the exposure period
(day 7) through day 21 of the postexposure period. The
elimination of DPN appeared to occur in 2 phases; therefore,
initial, terminal, and overall half-life were calculated. These half-
life calculations were conducted using the slope of the log
concentration versus time plot and the following equations:
slope¼ ke/–2.303 and t1/2¼ 0.693/ke, where ke is the elimination
rate constant.
Assessing the potential hazard of chemicals in toxicology has
often depended on the use of a no-observed-adverse-effect level
(NOAEL) and lowest-observed-adverse-effect level (LOAEL).
These estimates in risk assessment have been criticized because
they do not adequately describe the exposure–response
relationship. In the present study, the concentration of DPN in
the liver at which clotting time was prolonged in 10% of the
study owls (i.e., tissue-based toxicity reference value) was
estimated. The distribution of liver DPN concentrations was
divided into quintiles, and the mean DPN residue in a quintile
served as the dose. The response parameters included clotting
time (continuous, PT or RVVT values in seconds) and the
number of individuals with prolonged clotting time
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(dichotomous, number of owls in each liver DPN quintile with
PT or RVVT exceeding mean baseline clotting time value by 2
SDs). Using the dose–response curve, a benchmark dose at the
10% effect level and a benchmark dose low (lower bound of
the 95% confidence interval of benchmark dose 10%) was
calculated with different models (gamma, multistage, Weibull,
quantal-linear, logistic, log-logistic, probit, and log-probit) for
continuous and dichotomous data (Benchmark Dose software,
Ver 2.2 [14]). In addition, a benchmark dose was calculated for
threshold liver DPN concentrations at which 20%, 50%, and
90% of the study owls exhibited prolonged clotting time.
Models were evaluated based on Akaike’s information
criterion and p values for model fit. The benchmark dose
was estimated in a similar manner for kidney DPN residues and
clotting time.
RESULTS
Toxicity of diphacinone
Cumulative DPN consumption averaged 4.74mg/kg body
weight for owls provided the DPN-treated diet for 3 d (n¼ 5)
and, 7.98mg/kg body weight for individuals that had been
exposed for 7 d (n¼ 28; 5 from exposure periodþ 23 from
postexposure period; Table 1). The daily DPN dose during the
exposure period averaged 1.21 0.281mg/kg body weight-d.
Small, nonsignificant changes in body weight (6 toþ5 g/100 g
body wt) occurred during the trial, with the exception of a
marked increase in weight on day 21 postexposure (þ24 g/100 g
body wt). This weight gain is attributed to greater food
consumption accompanying cooler weather and changing
seasons toward the end of the trial.
On day 7 of DPN exposure and on day 1, day 2, and day 4 of
the postexposure peroid, several owls exhibited external signs of
bruising and internal evidence of hemorrhage (Table 1). The
incidence of these signs subsided after day 4 of the postexposure
period. Hematocrit values 30, presumably indicative of blood
loss anemia [15], were observed in 2 of 5 owls killed on day 7 of
DPN exposure and in 2 of 5 owls killed on day 1 of the
postexposure period.
Before the toxicity study, the baseline value (mean SD) for
PT was 9.3 1.87 s (range, 4.3–13.9 s) and that for RVVT was
19.0 3.08 s (range, 13.4–25.5 s). On day 3 of exposure, PTwas
not significantly different from controls (n¼ 7 bled over the
course of the study), but all day 3 PT values of exposed owls
(range, 13.6–21.9 s) exceeded both the mean of the controls and
the prestudy baseline mean by more than 2 SDs (Figure 1).
However, RVVT had increased significantly (p< 0.0001) on
day 3 of exposure compared with controls (Figure 2). Both PT
and RVVT values were significantly greater (p< 0.0001) than
controls by day 7. Upon termination of DPN exposure,
coagulopathy and anemia were resolved to baseline values
within 1 d to 4 d (Table 1).
Diphacinone residues and tissue half-life
Diphacinone residues in liver and kidney were greatest
during the exposure period, notably with average concentrations
in kidney exceeding those in liver (nonoverlapping ranges) by
over 3-fold (Table 1). Postexposure concentrations decreased
rapidly within 24 h; within 1 wk, liver and kidney values were
<0.3mg/g wet weight, and by 3 wk, values were <0.1mg/g
(liver, DPN detected in 2 of 3 owls; kidney, DPN detected in
only 1 of 3 owls). The elimination of DPN from liver seemed to
occur in 2 phases: an initial phase between day 7 of exposure and
day 2 postexposure with a half-life (t1/2) of 0.88 d, and then a
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slower loss rate between day 4 and day 21 postexposure with a
t1/2 of 29.2 d. The overall t1/2 was 11.7 d. Although the initial
concentration of DPN in kidney was greater than that in liver, t1/2
values indicate that it was cleared more rapidly than in liver.
Kidney DPN elimination was characterized by a rapid initial
phase t1/2 of 0.14 d and a slower terminal phase t1/2 of 10.2 d,
with an overall t1/2 of 2.1 d.
There was an association between liver and kidney DPN
residues in exposed owls (p< 0.0001, R2¼ 0.886). More
importantly, visual inspection of these data suggested there
might be a relation between prolonged clotting time and tissue
DPN residues. This was investigated by regression analysis
(p< 0.001; PT and liver DPN R2¼ 0.270, PT and kidney DPN
R2¼ 0.424; RVVT and liver DPN R2¼ 0.529, RVVT and
kidney DPN R2¼ 0.722), and with the exception of RVVT and
kidney DPN, predictive relationships were weak.
Tissue-based toxicity reference values
The concentration of DPN in the liver of the 37 owls that were
killed ranged from the method limit of detection to 2.93mg/g wet
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Figure 1. Prothrombin time (individual values in seconds,mean standard deviation) of eastern screech-owls fed diphacinone (DPN; 10mg/gwet wt) for up to 7 d
and then shifted to a diet of untreated mice for up to 21 d. Horizontal shaded line encompasses the range of baseline values determined 2 wk before the trial.
Untreated controls (0) included 4 owls fed Bird of Prey diet (days 1–7) and 3 owls fed only mice. Bars with different letters are significantly different (p< 0.05).
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Figure 2. Russell’s viper venom time (individual values in seconds, mean standard deviation) of eastern screech-owls fed diphacinone (DPN; 10mg/g wet wt)
for up to 7 d and then shifted to a diet of untreatedmice for up to 21 d. Horizontal shaded line encompasses the range of baseline values determined 2 wk before the
trial. Untreated controls (0) included 4 owls fed Bird of Prey diet (days 1–7) and 3 owls fed only mice. Bars with different letters are significantly different
(p< 0.05).
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weight. Quintile means of 0.044mg/g, 0.178mg/g, 0.320mg/g,
0.630mg/g, and 1.62mg/g liver were used as the concentration
(internal dose) in the benchmark dose 10% models. Based on
Akaike’s information criterion and visual inspection of the plots,
these model fits for continuously distributed PT and RVVT
values were not robust. Far better benchmark dose model fits
were achieved with dichotomous data, when the incidence of
prolonged PT and RVVT exceeding baseline (i.e., prestudy
meanþ 2 SDs for PT¼ 13.6 s and for RVVT¼ 25.2 s) was
analyzed with quintile dose. For PT, a logistic model yielded a
tissue-based toxicity reference value derived from benchmark
dose 10% calculations of 0.122mgDPN/g liver (benchmark dose
lower bound 10%¼ 0.075mg/g) (Figure 3). For PT, the DPN
concentrations at which 20%, 50%, and 90% of the study owls
exhibited coagulopathy were estimated to be 0.197mg DPN/g
liver, 0.345mg DPN/g liver, and 0.638mg DPN/g liver,
respectively. For Russell’s viper venom time, a log-logit model
yielded a better fit based on Akaike’s information criterion, with
a toxicity reference value of 0.282mg DPN/g liver (benchmark
dose lower bound 10%¼ 0.131mg/g; Figure 4). For RVVT, the
DPN concentrations at which 20%, 50%, and 90% of the study
owls exhibited coagulopathy were estimated to be 0.296mg
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Figure 3. Dose–response relation of liver diphacinone concentration and prothrombin time in eastern screech-owls. Using the benchmark dose method, a tissue-
based toxicity reference value at which prothrombin time in 10% of the test population exceeded the baselinemean by 2 standard deviations occurred at 0.122mg/g
wet weight (benchmark dose lower bound 10%¼ 0.075mg/g).
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Figure 4. Dose–response relation of liver diphacinone concentration andRussell’s viper venom time in eastern screech-owls. Using the benchmark dosemethod, a
tissue-based toxicity reference value at which Russell’s viper venom time in 10% of the test population exceeded the baseline mean by 2 standard deviations
occurred at 0.282mg/g wet weight (benchmark dose lower bound 10%¼ 0.131mg/g).
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DPN/g liver, 0.319mg DPN/g liver, and 0.361mg DPN/g liver,
respectively. When this analysis was conducted using kidney
DPN residues, the dichotomous grouping of clotting time in a
log-logistic model yielded the best fit. Because the proportion of
owls with prolonged PT and RVVT was identical for each
quintile dose, the toxicity reference value for both of these end
points was 0.800mg DPN/g kidney (benchmark dose lower
bound 10%¼ 0.351mg/g).
DISCUSSION
Ingestion of DPN by eastern screech-owls (10mg/g wet wt in
food) prolonged clotting time within 3 d of exposure (3-d
cumulative dose¼ 4.74mg/kg body wt), with more pronounced
effects on clotting time and anemia apparent on day 7 of
exposure (7-d cumulative dose¼ 7.98mg/kg body wt). This
time course of DPN toxicity expands on our previous
observations in eastern screech-owls [9] in which coagulopathy
was apparent at similar (7-d cumulative dose¼ 7.0mg/kg body
wt) and even lower (LOAEL 7-d cumulative dose¼ 1.68mg/kg
body wt) dietary exposure levels. The onset of coagulopathy was
not unlike that observed in a study of mixed-breed dogs (Canis
lupus familiaris) orally administered a total of 2.5mg DPN/kg
body weight (divided dose administered over 3 consecutive d)
[16]. The mechanism of action of DPN involves irreversible
inhibition of an epoxide reductase that is responsible for the
recycling of oxidized vitamin K to its active reduced form.
Vitamin K is necessary for the posttranslational carboxylation of
coagulation factors II, VII, IX, and X, which are required for the
formation of active clotting complexes on cell surfaces [17]. The
lag time between exposure and coagulopathy reflects the
decreased rates of carboxylation of these clotting factors and
the clearance of carboxylated clotting factors from blood
[16,17]. A similar time course for coagulopathy was also
observed in American kestrels following administration of a
much larger acute DPN dose (50mg/kg bodywt) [8]. However, a
large acute dose does not mimic the multiple-day, low-level field
exposures that result in mortality of rodent pest species [18,19]
and nontarget wildlife [9–11].
Clotting times and hematocrit of eastern screech-owls were
restored to baseline values within 2 d to 4 d following
termination of DPN exposure. This is in contrast to a 5-d dietary
exposure of golden eagles (Aquila chrysaetos) to DPN (2.7mg/g
wet wt in meat from dosed-sheep,Ovis aries; cumulative dose to
most sensitive individual¼ 0.55mg/kg body wt) that also
included daily bouts of physical exercise [20]. This exposure–
exercise regimen resulted in prolonged PT on day 5, with
maximal effects on PT occurring on day 10 (i.e., 5 d after
termination of DPN exposure) and recovery to initial values by
day 15 (i.e., 10 d postexposure). Likewise, coagulopathy and
reduced hematocrit persisted for more than 4 wk postexposure in
dogs orally administered DPN for 3 d [16]. The reasons for the
rapid recovery in owls compared with the more protracted
coagulopathy in golden eagles and dogs are unclear. Cumulative
exposure doses were relatively comparable between owls
(7.98mg/kg body wt) and dogs (2.5mg/kg body wt) and as
much as an order of magnitude lower for golden eagles (0.55mg/
kg body wt). Half-life estimates of DPN in liver of mammals (t1/
2¼ 3 d in laboratory rats, Rattus norvegicus; t1/2¼ 5.43
d in domestic pig, Sus scrofa) [21,22] are somewhat less than
that of screech-owls (overall t1/2¼ 11.7 d). Hydroxylation rates
of the first-generation anticoagulant rodenticide warfarin
(coumarin compound) in owls (great-horned owl [Bubo virgin-
ianus] and snowy owl [Bubo scandiacus]) are much lower than
that of the laboratory rat [23]; if a similar tendency exists for
DPN (indandione compound), recovery from coagulopathy
would be prolonged in DPN-exposed screech-owls, which was
not the case. Finally, owls were fed diets that contained synthetic
vitamin K (menadione sodium bisulfate complex), while golden
eagles received an unsupplemented diet of mutton. It is certainly
possible that the vitamin K in the formulated Bird of Prey diet or
in dead mice may have enhanced the recovery rate of screech-
owls compared to golden eagles. Thus, there is no simple
explanation of the more rapid recovery of hemostasis in screech-
owls compared with that in other species.
Tissue residues
Diagnosis of anticoagulant rodenticide poisoning in free-
ranging wildlife is difficult. The most definitive cases entail the
presence of postmortem signs of hemorrhage (independent of
trauma) coincident with the detection of rodenticide residues in
liver [4,24–27]. In some instances, hemorrhage may be apparent
only microscopically (e.g., Vyas and Rattner [8]), and often only
a limited suite of anticoagulant compounds is quantified. Such
determinations are strengthened by a detailed exposure history,
clinical signs including measurement of coagulation time, and
response to vitamin K treatment [25]. Hepatic concentrations of
anticoagulant rodenticides associated with adverse effects in
raptors have yet to be definitively established, but raptors found
dead have shown signs of coagulopathy at concentrations
ranging from >0.1mg/g to >0.4mg/g wet weight in liver
[4,5,24,27]. Diagnostic concentrations may be affected by
exposure dose and frequency of exposure. Liver residues of free-
ranging raptors diagnosed as having potentially or definitively
succumbed from DPN exposure (n¼ 12 incidents) range from
trace quantities to 3.5mg/g wet weight [4–7]. These values fall
within the range of liver DPN concentrations observed in
screech-owls in the present study (Table 1) and thus support the
environmental relevance of the 10mg/g dietary exposure
scenario. The observation of kidney DPN residues exceeding
concentrations in liver during exposure and through much of the
postexposure period was surprising. Furthermore, the relation
between DPN residues and prolonged clotting time in exposed
screech-owls was seemingly stronger for kidney than liver. Such
a relationship was not observed in kestrels following acute oral
exposure to DPN (B.A. Rattner, unpublished data) and is not the
case in numerous first- and second-generation anticoagulant
rodenticide tissue distribution studies in mammals (e.g.,
Vandenbroucke et al. [28] and Johnston et al. [29]). To the
best of our knowledge, diagnostic investigations of poisoned
raptors have not included first- or second-generation anticoagu-
lant rodenticide residue measurements in kidney. While the liver
is considered to be the principal target organ of these
rodenticides, the kidney does contain vitamin K epoxide
reductase activity, albeit at much lower levels than in the liver
[30]. Thus, it is not clear if the seemingly greater residues in the
kidney are commonplace in raptors, unique to owls, or possibly
an artifact of the exposure regimen employed in the present
study. Measurement of first- and second-generation anticoagu-
lant rodenticides in kidney tissue of poisoned raptors and other
nontarget wildlife deserves further attention and could poten-
tially aid in the diagnosis of mortality events.
Due to their greater affinity to binding sites [29] and long
half-life in the liver (e.g., 80–307 d for brodifacoum) [1,31],
second-generation anticoagulant rodenticides are more toxic
than first-generation anticoagulant rodenticides and thus account
for the vast majority of nontarget mortality incidents involving
rodenticides [4,5,24,27]. The short half-life of first-generation
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anticoagulant rodenticides requires multiday exposure to elicit
toxicity in target rodents [18]. For free-ranging nontarget raptors,
empirical DPN toxicity data, tissue half-life estimates, and
predictions from risk assessments suggest that multiday
exposure to poisoned rodents is required to elicit adverse effects
[8–10,32,33]. In fact, there have been relatively few reported
cases of DPN poisoning in nontarget wildlife, although its short
tissue half-life may impede identification of its role in some
mortality incidents. It is noteworthy that some eradication
projects with second-generation anticoagulant rodenticides have
used DPN as a secondary bait [34], and laboratory studies have
demonstrated that exposure to the second-generation anticoagu-
lant rodenticide brodifacoum increases the sensitivity of
laboratory rats exposed weeks later to the first-generation
anticoagulant rodenticide warfarin [35]. Residues of both first-
and second-generation anticoagulant rodenticides are occasion-
ally found in a single liver sample in a nontarget wildlife
incident, and in such circumstances it is certainly possible that
mortality due to first-generation anticoagulant rodenticides could
be underdiagnosed.
Potential application of toxicity reference values
The hazard of first- and second-generation anticoagulant
rodenticides to nontarget wildlife has principally been evaluated
by deterministic risk assessments using NOAELs and LOAELs
in a hazard quotient [6,33]. This approach has been critiqued and
criticized by many, because NOAEL and LOAEL values are
highly dependent on study design (e.g., dose interval, sample
size, method of dose administration) and often ignore the shape
of the dose–response relationships [36,37]. Notably, first-
generation anticoagulant rodenticide nontarget wildlife assess-
ments have begun to use more robust probabilistic approaches to
address hazard [9,10,32]. For example, using data derived from a
study in eastern screech-owls [9,10], model predictions allowed
estimation of the distribution of risk (e.g., coagulopathy,
mortality) associated with low-level dietary DPN exposure of
2 endangered raptors in Hawaii (USA). Furthermore, a dose-
based toxicity reference value associated with anemia in adult
screech-owls was estimated to be 0.17mg DPN consumed/kg
body weight-d [10].
In the present study, a range of internal DPN doses in the liver
and the fraction of individuals exhibiting prolonged clotting time
were modeled using a benchmark dose approach to derive tissue-
based toxicity reference values at which 10% of the study
population exhibited prolonged clotting time. The toxicity
reference values derived from the benchmark dose 10% in adult
screech-owls (0.122mg DPN/g liver for PT and 0.282mg DPN/g
liver for Russell’s viper venom time) are at the low end of DPN
concentrations associated with mortality events in raptors [4–7]
and may be appropriate for threatened and endangered species.
For abundant species, however, these diagnostic thresholds are
not particularly useful because 90% of the birds would not be
affected. In such circumstances, a benchmark dose encompass-
ing a larger fraction of the population may be applied (e.g.,
benchmark dose 50% or 90%). The threshold at which 90% of
exposed individuals exhibit coagulopathy would occur at
0.638mg DPN/g liver for PT and 0.361mg DPN/g liver for
RVVT. Since the dose–response curve is steep, these benchmark
dose 90% concentrations still fall in the range of DPN liver
values in raptor mortality events. In combination with
uncertainty factors, these toxicity reference values (benchmark
dose 10% and 50% or 90%) may have application for
interpreting the significance of hepatic DPN residues in suspect
raptor mortality incidents. It is important to note that prolonged
clotting time is a sublethal effect and is not equivalent to death.
Because the present study utilized a 7-d no-choice dietary
exposure regime, these toxicity reference values would be most
applicable to island eradication projects or large-scale agricul-
tural settings where raptors would have more limited access to
unexposed rodent prey.
CONCLUSIONS
Diphacinone is widely used in urban and agricultural settings
and has been used as primary or secondary bait in over 50
eradication projects [34]. Our findings demonstrate that
continuous dietary exposure to seemingly environmentally
realistic concentrations of this first-generation anticoagulant
rodenticide can evoke toxicity (overt signs of intoxication,
prolonged clotting time, and anemia) in eastern screech-owls in a
matter of days. Coagulopathy is associated with liver DPN
concentrations exceeding approximately 0.1mg/g wet weight;
because of its short half-life in tissues, however, once exposure is
terminated, recovery occurs rapidly. In order to translate these
findings from captive owls to environmentally relevant exposure
scenarios, natural resource managers must consider the duration
of access to contaminated prey species to predict potential
adverse effects on nontarget raptors.
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